Post-bypass Prophylactic IVIG in Infants and Neonates
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study protocol is to determine if administering Intravenous
Immunoglobulin (IVIG) for treatment of cardiopulmonary bypass (CPB) induced
hypogammaglobulinemia in the early post-operative period can impact post-surgical outcomes
(i.e., infection, fluid overload, and associated morbidities).